Elevation Oncology Net Debt Over Time
| ELEV Stock | USD 0.60 0.01 1.64% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Elevation Oncology Performance and Elevation Oncology Correlation. Elevation |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elevation Oncology. If investors know Elevation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elevation Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.25) | Return On Equity (0.64) |
The market value of Elevation Oncology is measured differently than its book value, which is the value of Elevation that is recorded on the company's balance sheet. Investors also form their own opinion of Elevation Oncology's value that differs from its market value or its book value, called intrinsic value, which is Elevation Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elevation Oncology's market value can be influenced by many factors that don't directly affect Elevation Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elevation Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Elevation Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elevation Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Debt Analysis
Compare Elevation Oncology and related stocks such as CohBar Inc, Ocean Biomedical, and AVROBIO Net Debt Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OCEA | (60 K) | (60 K) | (60 K) | (60 K) | (60 K) | (60 K) | (60 K) | (60 K) | (60 K) | (60 K) | (60 K) | (60 K) | 1.8 M | 2.1 M | 2.2 M |
| ZURA | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | (4.7 M) | 341.8 K | (99.8 M) | (94.8 M) |
| ENVB | (1.5 M) | (18.2 K) | 6.6 K | 1.8 K | (5.1 K) | 4.4 M | 3.7 M | 2.3 M | 3.8 M | 4.4 M | (1.6 M) | (17.2 M) | (17.7 M) | (2.3 M) | (2.2 M) |
| HEPA | (86.7 K) | (86.7 K) | (86.7 K) | (1.8 M) | (1.8 M) | (4.6 M) | (7.4 M) | (13 M) | (1.4 M) | (13.1 M) | (40 M) | (91 M) | (51.1 M) | (14.6 M) | (15.3 M) |
Elevation Oncology and related stocks such as CohBar Inc, Ocean Biomedical, and AVROBIO Net Debt description
The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.My Equities
My Current Equities and Potential Positions
| Elevation Oncology | ELEV |
| Classification | Pharmaceutical Products |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.6
Additional Tools for Elevation Stock Analysis
When running Elevation Oncology's price analysis, check to measure Elevation Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevation Oncology is operating at the current time. Most of Elevation Oncology's value examination focuses on studying past and present price action to predict the probability of Elevation Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevation Oncology's price. Additionally, you may evaluate how the addition of Elevation Oncology to your portfolios can decrease your overall portfolio volatility.